|
BCL10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.636590E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.201430E-04 |
| Normal-vs-Stage2 |
3.040800E-01 |
| Normal-vs-Stage3 |
6.637200E-01 |
| Normal-vs-Stage4 |
5.842800E-01 |
| Stage1-vs-Stage2 |
4.219600E-01 |
| Stage1-vs-Stage3 |
2.615800E-01 |
| Stage1-vs-Stage4 |
7.032300E-02 |
| Stage2-vs-Stage3 |
7.335000E-01 |
| Stage2-vs-Stage4 |
6.727000E-01 |
| Stage3-vs-Stage4 |
9.530200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0648000000032E-05 |
| Normal-vs-AfricanAmerican |
4.057700E-02 |
| Normal-vs-Asian |
1.780030E-01 |
| Caucasian-vs-AfricanAmerican |
1.408990E-01 |
| Caucasian-vs-Asian |
5.921000E-01 |
| AfricanAmerican-vs-Asian |
9.952800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30310000001632E-06 |
| Normal-vs-Female |
3.306400E-01 |
| Male-vs-Female |
1.631630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.376210E-03 |
| Normal-vs-Extreme_Weight |
2.66250000047208E-07 |
| Normal-vs-Obese |
6.341600E-02 |
| Normal-vs-Extreme_Obese |
9.522100E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.110400E-01 |
| Normal_Weight-vs-Obese |
4.823400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.299200E-01 |
| Extreme_Weight-vs-Obese |
1.175810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.900600E-01 |
| Obese-vs-Extreme_Obese |
5.445000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.806200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.035340E-03 |
| Normal-vs-Age(61-80Yrs) |
1.560670E-04 |
| Normal-vs-Age(81-100Yrs) |
3.619900000007E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.302400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.675190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.958300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.305200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.944300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.748100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.39020000000656E-06 |
| Normal-VS-Type2 PRCC |
7.94139999982235E-07 |
| Normal-VS-KIRP CIMP |
1.082810E-01 |
| Normal-VS-Unclassified PRCC |
1.104460E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.184000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.414000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.908600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.988300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.279800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.095900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0207999999734E-06 |
| Normal-vs-N1 |
6.907800E-01 |
| Normal-vs-N2 |
1.622180E-01 |
| N0-vs-N1 |
4.591600E-02 |
| N0-vs-N2 |
4.943600E-01 |
| N1-vs-N2 |
5.357800E-01 |
|
|
